Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.06
+0.43 (5.64%)
Nov 11, 2026, 4:00 PM EST - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $529.88 million as of November 11, 2026. Its market cap has increased by 69.12% in one year.
Market Cap
529.88M
Enterprise Value
436.70M
1-Year Change
69.12%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $529.88M, an increase of 759.94%. That is a compound annual growth rate of 46.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 529.88M | 39.00% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 528.45M |
| Neurogene | 523.32M |
| DiaMedica Therapeutics | 521.46M |
| Capricor Therapeutics | 515.69M |
| SL Science Holding | 512.67M |
| REGENXBIO | 508.48M |
| Electra Therapeutics | 501.51M |
| Shattuck Labs | 493.94M |